JANIECE BRIDGES: Open Payments
NPI 1184758617 · FORSYTH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$991 in 49 payments from 18 companies in 2025. Trend: 2023 $1,357 · 2024 $1,033 · 2025 $991
Food & beverage: $991
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 6 | $185 |
| AstraZeneca Pharmaceuticals LP | 6 | $99 |
| Novo Nordisk Inc | 5 | $93 |
| Abbott Laboratories | 4 | $93 |
| Viatris Specialty LLC | 4 | $68 |
| PFIZER INC. | 3 | $54 |
| Exact Sciences Corporation | 3 | $53 |
| Lilly USA, LLC | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
Products named: Senza, FREESTYLE LIBRE, REXULTI, YUPELRI, FARXIGA, Ozempic, MOUNJARO, CAPLYTA.
Industry payments across MO — which companies pay providers there.
